<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Griffiths SC</submitter><funding>Cancer Research UK</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Wellcome Trust</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>e71980</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11219042</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13</volume><pubmed_abstract>The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secre</pubmed_abstract><journal>eLife</journal><pubmed_title>Structure and function of the ROR2 cysteine-rich domain in vertebrate noncanonical WNT5A signaling.</pubmed_title><pmcid>PMC11219042</pmcid><funding_grant_id>10.35802/099675</funding_grant_id><funding_grant_id>26752</funding_grant_id><funding_grant_id>DRCRPG-May23/100002</funding_grant_id><funding_grant_id>C20724/A26752</funding_grant_id><funding_grant_id>099675/Z/12/Z</funding_grant_id><funding_grant_id>10.35802/203141</funding_grant_id><funding_grant_id>1R35GM119574</funding_grant_id><funding_grant_id>R35 GM144341</funding_grant_id><funding_grant_id>203141/Z/16/Z</funding_grant_id><funding_grant_id>S10 OD018223</funding_grant_id><funding_grant_id>203141</funding_grant_id><funding_grant_id>2P30CA093373-19</funding_grant_id><funding_grant_id>P30 CA093373</funding_grant_id><funding_grant_id>1R35GM144341</funding_grant_id><funding_grant_id>R35 GM119574</funding_grant_id><pubmed_authors>Ho HH</pubmed_authors><pubmed_authors>Blazer LL</pubmed_authors><pubmed_authors>Tan J</pubmed_authors><pubmed_authors>Sidhu SS</pubmed_authors><pubmed_authors>Srinivasan S</pubmed_authors><pubmed_authors>Griffiths SC</pubmed_authors><pubmed_authors>Adams JJ</pubmed_authors><pubmed_authors>Wagner A</pubmed_authors><pubmed_authors>Moghisaei S</pubmed_authors><pubmed_authors>Siebold C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structure and function of the ROR2 cysteine-rich domain in vertebrate noncanonical WNT5A signaling.</name><description>The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secre</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-01T21:27:09.942Z</modification><creation>2025-04-04T12:22:04.471Z</creation></dates><accession>S-EPMC11219042</accession><cross_references><pubmed>38780011</pubmed><doi>10.7554/eLife.71980</doi></cross_references></HashMap>